Antiinflammation Effects and Mechanisms Study of Geniposide on Rats with Collagen-Induced Arthritis

被引:38
作者
Wang, Rong [1 ]
Wu, Hong [1 ]
Chen, Jian [2 ]
Li, Shu-Ping [1 ]
Dai, Li [1 ]
Zhang, Zheng-Rong [1 ]
Wang, Wen-Yu [1 ]
机构
[1] Anhui Univ Chinese Med, Coll Pharm, Key Lab Modernized Chinese Med Anhui Prov, Hefei 230012, Anhui, Peoples R China
[2] Univ Sci & Technol China, Anhui Inst Opt & Fine Mech, Hefei 230031, Peoples R China
基金
中国国家自然科学基金;
关键词
geniposide; mesenteric lymph node lymphocytes; inflammation; Erk1/2 signaling pathway; MUCOSAL IMMUNE-SYSTEM; RHEUMATOID-ARTHRITIS; JOINT DAMAGE; T-CELLS; SINOMENINE; IL-6; INFLAMMATION; REGULATOR; DELIVERY; TH1/TH2;
D O I
10.1002/ptr.5775
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Geniposide (GE), an iridoid glycoside compound purified from Gardenia jasminoides Ellis, has antiinflammatory and other pharmacological effects, but its mechanism of actions on rheumatoid arthritis (RA) have not been clarified. The purpose of this article was to investigate the pharmacological effects of GE on collagen-induced arthritis (CIA) rats and its feasible mechanisms. Collagen-induced arthritis was induced by injection of chicken type II collagen emulsion. The rats were orally administered with GE (33, 66, and 132 mg/kg) from days 14 to 30 after immunization. The histological examination showed that GE could attenuate histopathologic changes of mesenteric lymph node (MLN) in CIA rats. Geniposide inhibited the production of Interleukin 6 (IL-6) and IL-17, while promoting the production of IL-4 and transforming growth factor-beta 1 in MLN lymphocytes (MLNLs). Moreover, the proliferation capability of MLNLs was increased after the administration of GE. In addition, the treatment with GE in vivo decreased the expressions of P-Raf, P-MEK, and P-Erk1/2 in MLNLs. These results may highlight the antiinflammatory effects and possible mechanisms of GE in MLNLs of RA. Copyright (c) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:631 / 637
页数:7
相关论文
共 53 条
  • [1] Regulation of Th2 differentiation and Il4 locus accessibility
    Ansel, K. Mark
    Djuretic, Ivana
    Tanasa, Bogdan
    Rao, Anjana
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 607 - 656
  • [2] Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model
    Bae, Joonho
    Park, Jin Woo
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (02) : 254 - 262
  • [3] The mucosal immune system: Recent developments and future directions in the pig
    Bailey, Mick
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2009, 33 (03) : 375 - 383
  • [4] Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib
    Bilthariya, Upasana
    Jain, Nivrati
    Rajoriya, Vaibhav
    Jain, Ashish Kumar
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (01) : 95 - 104
  • [5] Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigm
    Boissier, Marie-Christophe
    Assier, Eric
    Falgarone, Geraldine
    Bessis, Natacha
    [J]. JOINT BONE SPINE, 2008, 75 (04) : 373 - 375
  • [6] Rheumatic autoimmune diseases: Proposed elimination of autoreactive B-cells with magnetic nanoparticle-linked antigens
    Bollmann, F. Mathias
    [J]. MEDICAL HYPOTHESES, 2012, 78 (04) : 479 - 481
  • [7] Collagen-induced arthritis
    Brand, David D.
    Latham, Kary A.
    Rosloniec, Edward F.
    [J]. NATURE PROTOCOLS, 2007, 2 (05) : 1269 - 1275
  • [8] Immunopathogenesis of collagen arthritis
    Brand, DD
    Kang, AH
    Rosloniec, EF
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 25 (01): : 3 - 18
  • [9] The impact of biological therapy on regulatory T cells in rheumatoid arthritis
    Byng-Maddick, Rachel
    Ehrenstein, Michael R.
    [J]. RHEUMATOLOGY, 2015, 54 (05) : 768 - 775
  • [10] Madecassoside suppresses LPS-induced TNF-α. production in cardiomyocytes through inhibition of ERK, p38, and NF-κB activity
    Cao, Wei
    Li, Xiao-Qiang
    Zhang, Xiao-Nan
    Hou, Ying
    Zeng, Ai-Guo
    Xie, Yan-hua
    Wang, Si-Wang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (07) : 723 - 729